SCHEMBL7296108

SCHEMBL7296108

NC(=O)NCC1CCCC1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.82
EPHX1 P07099 4/20 0.57
CYP2D6 P10635 1/20 0.57
CA2 P00918 2/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
MMP1 P03956 1/20 0.53
MMP2 P08253 1/20 0.53
MMP3 P08254 1/20 0.53
MMP9 P14780 1/20 0.53
MMP8 P22894 1/20 0.53
CA9 Q16790 1/20 0.53
TSHR P16473 2/20 0.47
ALOX5 P09917 2/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ADH1B P00325 1/20 0.41
ADH1C P00326 1/20 0.41
ADH1A P07327 1/20 0.41
ADH4 P08319 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1050014 0.98 TDP1 (0.78) TDP1EPHX1CYP2D6CA2CA12
SCHEMBL2285048 0.98 TDP1 (0.78) TDP1EPHX1CYP2D6CA2CA12
SCHEMBL7296555 0.95
SCHEMBL2000699 0.90
SCHEMBL18380898 0.86 TDP1 (0.68) TDP1EPHX1CYP2D6CA2CA12
SCHEMBL13999422 0.82 TDP1 (0.83) TDP1EPHX1CYP2D6CA2CA12
SCHEMBL4697448 0.82 TDP1 (0.83) TDP1EPHX1CYP2D6CA2CA12
SCHEMBL18028783 0.80 TDP1 (0.72) TDP1EPHX1CYP2D6CA2CA12
SCHEMBL7350548 0.80 TDP1 (0.72) TDP1EPHX1CYP2D6TSHR
SCHEMBL7022372 0.80 EPHX1 (0.69) TDP1EPHX1CYP2D6CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008059128-A1 PHENYLIC DERIVATIVES AND USE THEREOF AS DRUGS IPSEN PHARMA S.A.S. (FR) 2008-05-22 WO disclosed
EP-0389282-B1 Xanthinederivatives, process for their preparation and their pharmaceutical use SMITHKLINE BEECHAM PHARMA GMBH (DE) 2002-02-20 EP disclosed
US-5864043-A CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST KARL THOMAE GMBH (DE) 1999-01-26 US disclosed
US-5541229-A ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-07-30 US disclosed
CN-1031641-C Process for preparing 8-substituted xanthine BEECHAM WUELFING GMBH & CO KG (DE) 1996-04-24 CN disclosed
CN-1047502-A The preparation method of 8-substituted xanthine BEECHAM WUELFING GMBH & CO KG (DE) 1990-12-05 CN disclosed
US-3984416-A Substituted quinoline-8-carboxamido ethyl benzene-sulfonyl N-cyclopentylmethyl urea HOECHST AKTIENGESELLSCHAFT (DT) 1976-10-05 US disclosed